Amy Early
Impact in
- Hematology top 2%
- Acute Myeloid Leukemia Research
- Hematopoietic Stem Cell Transplantation
-
- Acute Lymphoblastic Leukemia research
Papers in
-
- Acute Myeloid Leukemia Research 5
- Hematopoietic Stem Cell Transplantation 4
-
- Acute Lymphoblastic Leukemia research 7
- Co-authors
- Harvey D. Preisler (7 shared papers)Harry K. Slocum (2 shared papers)Azra Raza (3 shared papers)George P. Browman (3 shared papers)Martin L. Brecher (3 shared papers)Michelle J. Marinello (2 shared papers)Sandhya Pruthi (1 shared paper)James A. Simon (1 shared paper)
- Journals
- Clinical Breast Cancer (3 papers)American Journal of Hematology (2 papers)New England Journal of Medicine (1 paper)Frontiers in Oncology (1 paper)The Breast Journal (1 paper)
- Partner nations
- United StatesCanada
In The Last Decade
Amy Early
22 papers receiving 572 citations
Peers
Comparison fields: 5 of 50
- Hematology 355
- Public Health, Environmental and Occupational Health 266
- Genetics 95
- Oncology 195
- Pulmonary and Respiratory Medicine 112
Countries citing papers authored by Amy Early
This map shows the geographic impact of Amy Early's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amy Early with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amy Early more than expected).
Fields of papers citing papers by Amy Early
This network shows the impact of papers produced by Amy Early. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amy Early. The network helps show where Amy Early may publish in the future.
Co-authors
The 25 scholars most cited alongside Amy Early, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 22 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | A pilot study of high-dose 1-beta-D-arabinofuranosylcytosine for acute leukemia and refractory lymphoma: clinical response and pharmacology. | 1982 | 173 |
| 2 | 1983 | 115 | |
| 3 | 1987 | 72 | |
| 4 | 2011 | 48 | |
| 5 | 1982 | 43 | |
| 6 | 2017 | 38 | |
| 7 | 2020 | 29 | |
| 8 | 1982 | 25 | |
| 9 | 1982 | 22 | |
| 10 | 2018 | 22 | |
| 11 | 2022 | 12 | |
| 12 | 2021 | 11 | |
| 13 | 2023 | 11 | |
| 14 | 1981 | 9 | |
| 15 | 1981 | 8 | |
| 16 | 2020 | 8 | |
| 17 | 1985 | 6 | |
| 18 | 2024 | 3 | |
| 19 | 2022 | 2 | |
| 20 | 1983 | 2 |
About Amy Early
Amy Early is a scholar working on Hematology, Public Health, Environmental and Occupational Health, Pulmonary and Respiratory Medicine, Oncology and Radiology, Nuclear Medicine and Imaging, having authored 22 papers that have together received 661 indexed citations. Recurring topics across this work include Acute Lymphoblastic Leukemia research (7 papers), Acute Myeloid Leukemia Research (5 papers), Hematopoietic Stem Cell Transplantation (4 papers), Neutropenia and Cancer Infections (4 papers), Lung Cancer Treatments and Mutations (3 papers), Advanced Breast Cancer Therapies (2 papers), Metastasis and carcinoma case studies (1 paper) and DNA Repair Mechanisms (1 paper). The work is most often cited by research in Hematology (355 citations), Public Health, Environmental and Occupational Health (266 citations), Genetics (95 citations), Oncology (195 citations) and Pulmonary and Respiratory Medicine (112 citations). Amy Early has collaborated with scholars based in United States and Canada. Frequent co-authors include Harvey D. Preisler, Harry K. Slocum, Azra Raza, George P. Browman, Martin L. Brecher, Michelle J. Marinello, Sandhya Pruthi, James A. Simon, Arnold I. Freeman and Nozar Azarnia. Their work appears in journals such as Clinical Breast Cancer, American Journal of Hematology, New England Journal of Medicine, Frontiers in Oncology and The Breast Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.